GlassScriptPhysician profile
Steven L Simmons
NPI 1104815505
$9,738.02
in general payments reported to CMS, 2019-2025
53 companies · $452 in 2025
The $452 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,219 · 2020: $3,383 · 2021: $1,154 · 2022: $1,344 · 2023: $1,497 · 2024: $689 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,404 · Travel and Lodging: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,404.39 |
| Travel and Lodging | $234.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanos Medical | $3,021.94 | 2020-2023 | Coolief* Cooled Radiofrequency |
| Abbvie INC. | $595.82 | 2021-2025 | Botox |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $474.01 | 2019-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $472.34 | 2019-2025 | Belbuca |
| Amgen INC. | $409.41 | 2019-2022 | |
| Angiodynamics, INC. | $371.71 | 2019-2025 | Venacure 1470 Pro |
| Stratus Medical, LLC | $336.02 | 2022-2023 | Nimbus |
| Pfizer INC. | $322.56 | 2019-2025 | |
| Arthrex, INC. | $272.08 | 2023 | |
| Almatica Pharma LLC | $262.18 | 2021-2023 | Gralise, Loreev Xr |
| Zyla Life Sciences, INC. | $261.33 | 2019-2020 | |
| Pylant Medical | $250.68 | 2021-2023 | |
| Mml US, INC. | $224.68 | 2022-2023 | Reactiv8 |
| Tactile Systems Technology INC | $191.41 | 2019-2022 | |
| Merz Pharmaceuticals, LLC | $182.81 | 2023-2024 | Xeomin |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Simmons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.